Guangzhou Institutes of Biomedicine and Health (GIBH)，(simplified Chinese: 中国科学院广州生物医药与健康研究院; traditional Chinese: 中國科學院廣州生物醫藥與健康研究院; pinyin: Zhōngguó Kēxué yuan guangzhou sheng wu yi yao yu jian kang yan jiu yuan) affiliated with the Chinese Academy of Sciences, is a government-sponsored scientific research institution with independent legal jurisdiction. GIBH was established by the Chinese Academy of Sciences, Guangdong Provincial Government and Guangzhou Municipal Government. The managerial mechanism of GIBH is the responsibility of Director-General, under the authority of the board of trustees.

Huai'an First People's Hospital, a subsidiary of Nanjing Medical University, is a Chinese company located in Huai'an. The firm provides healthcare services.

TES is a manufacturer of semiconductors and solar cell equipment equipped with technological prowess. It has contributed hugely to turning Korea into a powerhouse in the semiconductor and solar cell industries that is recognized all around the world. It secures technological competitiveness and practicing sound business principles for providing exemplary customer satisfaction.

Otsuka Pharmaceutical Factory, Inc. manufactures and distributes pharmaceutical and nutritional products. Its products include medical foods, hine E-gel, processlead, engelead, innerpower, oronine h ointment, urepearl plus lotion 10 and urepearl plus cream. The company was founded on September 1, 1921 and is headquartered in Naruto, Japan.

Riken Corp. engages in the manufacture and sale of engine and vehicular components. It operates through the Automotive and Machinery Parts, and Others segments. The Automotive and Machinery Parts segment deals with the company's core products such as piston rings, camshafts, seal rings for transmissions, high-grade cast iron products, and valve lifters. The Others segment includes plumbing equipment business, Electromagnetic Compatibility (EMC) business, and thermal engineering business, The company was founded by Masatoshi Okochi in November 1927 and is headquartered in Tokyo, Japan.

SYBLEU, Inc. intends to engage in the development of regenerative medical applications. After conducting successful Phase I or Phase II clinical trials, it would either attempt to sell or license those developed applications or advance the application further to Phase III clinical trials. The company was founded on June 12, 2020 and is headquartered in Bronx, NY.

Beam Therapeutics is a biotechnology company engaged in creating genetic medicines based on its base editing technology. It is pioneering the use of base editing, a potential new class of precision genetic medicines, with a vision of providing life-long cures to patients suffering from serious diseases. This technology enables a new class of genetic medicines that targets a single base in the genome without making a double-stranded break in the dna.

Korea Research Institute of Bioscience and Biotechnology (KRIBB) is a government research institute in Daejeon, South Korea. It is dedicated to biotechnology research across a broad span of expertise, from basic studies for the fundamental understanding of life phenomena to applied studies such as drug discovery, novel biomaterials, integrated biotechnology and bioinformation.

Guangdong Qianhui Biotechnology Co., Ltd., established on 2011-03-22, Business scope includes general business items:Biomedical Technology Development,Technical Services,technical consulting,technology transfer.,The licensing program is:none

Yulin Tech Biomedical Nantong Co., Ltd, established on 2015-06-12, Business scope includes licensed projects:Production of formula food for special medical purpose(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments,Specific business projects are subject to approval results) General project:R&D and application of cell technology;Human stem cell technology development and application;Medical Research and Experimental Development;Technical Services,technology development,technical consulting,Technology Exchange,technology transfer,Technology Promotion(Except for projects subject to approval by law,Carry out business activities independently in accordance with the law with a business license)

Foresight Mingchuang Pharmaceutical Technology (Suzhou) Co., Ltd., established on 2022-03-25, Business scope includes licensed projects:Experimental animal management;Experimental animal production;Drug Clinical Trial Services;Inspection and testing service(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments,Specific business projects are subject to approval results) General project:Technical Services,technology development,technical consulting,Technology Exchange,technology transfer,Technology Promotion;R&D and application of cell technology;Human stem cell technology development and application;Development of Human Gene Diagnosis and Therapy Technology;Medical Research and Experimental Development;Engineering and Technology Research and Experimental Development;Natural science research and experimental development;Information Technology Consulting Services;Information Consulting Service(Not including licensing information consulting services);Engineering Management Services;business management;software development;Software outsourcing service;Educational Consulting Services(Education and training activities that do not include licensing approval);Health Consulting Services(Does not include medical services);Conference and Exhibition Services;Technical extension services;Technology promotion and application services;Standardized service;Medical Research and Experimental Development(remove human stem cells,Development and application of genetic diagnosis and treatment technology);business training(Does not include education and training,Vocational skills training and other licensed training);Technology intermediary service;Biochemical product technology research and development;Fermentation process optimization technology research and development;Professional Design Services;Offline Data Processing Services;data processing services;Class I Medical Device Leasing;Sales of Class I Medical Devices;Veterinary special equipment sales;Sales of hygiene products and single-use medical products;Experimental analysis instrument sales;Drug testing equipment sales;drawing,Sales of computing and measuring instruments;Sales of daily chemical products;Specialty Chemicals Sales(Free of Hazardous Chemicals);Optical Instrument Sales;internet sales(Except for products that require a license for sale);sales agent;Class II Medical Device Leasing;Sales of Class II Medical Devices;Import and export;Technology Import and Export;Import and export agency(Except for projects subject to approval by law,Carry out business activities independently in accordance with the law with a business license)

PhoenixBio Co., Ltd. operates as a holding company that develops technologies for mass propagation of human cells into laboratory animals. Its solutions encompass PXB mouse services, Tg & KO animal services, and hair regeneration projects. It also offers its technologies to researchers by conducting in-house study services with custom produced transgenic animals. The company was founded on March 4, 2002 and is headquartered in Higashi-Hiroshima, Japan.

Shenzhen Vivo Biomedical Technology Co., Ltd., established on 2014-06-25, Business scope includes general business items:Technology development of biopharmaceutical products,Import and export of goods and technology.,The licensing program is:Sales of biopharmaceutical products.